Filing Details

Accession Number:
0000820081-14-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-08 15:34:28
Reporting Period:
2014-08-07
Filing Date:
2014-08-08
Accepted Time:
2014-08-08 15:34:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820081 Cambrex Corp CBM Pharmaceutical Preparations (2834) 222476135
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192621 M Steven Klosk 1 Meadowlands Plaza
East Rutherford NJ 07073
President & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-07 1,200 $5.61 147,070 No 4 M Direct
Common Stock Disposition 2014-08-07 1,200 $22.52 145,870 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-08-07 1,200 $0.00 1,200 $5.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
130,959 2015-05-14 No 4 M Direct
Footnotes
  1. The option, representing a right to purchase a total of 150,000 shares, became exercisable in four equal annual installments beginning on May 14, 2009, which was the first anniversary of the date on which the option was granted.